TWST

Twist Bioscience Corporation NASDAQ

Healthcare ·Medical - Diagnostics & Research ·US · twistbioscience.com

$56.19

Mkt Cap $3.4B

52w Low $23.30 76.9% of range 52w High $66.06

50d MA $50.67 200d MA $37.46

P/E (TTM) -46.5x

EV/EBITDA -31.4x

P/B 7.6x

Debt/Equity 0.3x

ROE -16.8%

P/FCF -22.3x

RSI (14) —

ATR (14) —

Beta 2.21

50d MA $50.67

200d MA $37.46

Avg Volume 1.3M

About

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital d…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 2, 2026	AMC	-0.48	-0.50	-4.2%	46.81	-0.4%	-1.0%	+2.8%	+0.6%	+5.2%	+1.4%	+2.7%	—
Nov 14, 2025	AMC	-0.50	-0.45	+10.0%	26.87	-0.5%	-1.5%	-3.2%	-5.3%	-3.0%	+6.3%	+15.6%	—
Aug 4, 2025	AMC	-0.54	-0.47	+13.0%	30.21	+2.6%	-8.9%	-14.3%	-17.2%	-15.1%	-8.5%	-13.9%	—
May 5, 2025	AMC	-0.56	-0.66	-17.9%	35.93	-1.7%	-8.9%	-8.8%	-9.2%	-14.2%	-8.3%	-15.3%	—
Feb 3, 2025	AMC	-0.62	-0.53	+14.5%	52.75	+1.2%	-1.4%	+1.7%	+1.8%	-0.9%	-7.8%	-20.3%	—
Nov 18, 2024	AMC	-0.71	-0.59	+17.4%	41.43	+0.7%	-0.3%	-0.8%	+0.6%	+1.9%	+12.0%	+7.7%	—
Aug 2, 2024	AMC	-0.79	-0.86	-8.9%	42.97	-9.3%	+5.5%	+7.6%	+3.7%	+5.7%	+2.3%	-4.7%	—
May 2, 2024	AMC	-0.84	-0.79	+6.0%	32.01	+19.6%	+28.7%	+39.6%	+34.7%	+29.3%	+35.0%	+37.5%	—
Feb 2, 2024	AMC	-0.80	-0.75	+6.2%	36.59	-3.0%	-0.5%	+1.0%	-4.4%	-0.2%	+4.4%	+4.5%	—
Nov 17, 2023	AMC	-0.94	-0.81	+13.8%	24.01	+3.6%	+3.0%	-1.2%	-0.8%	+2.0%	+0.2%	+43.9%	—
Aug 4, 2023	AMC	-1.14	-1.01	+11.4%	22.98	-0.4%	+3.4%	+1.5%	-1.7%	-0.8%	-2.9%	+2.0%	—
May 5, 2023	AMC	-1.09	-1.06	+2.8%	12.89	+0.2%	+4.0%	+4.9%	+2.5%	-1.5%	-7.3%	+25.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 14	Barclays	Maintains	Overweight → Overweight	—	$50.38	$51.00	+1.2%	+14.0%	+14.4%	+11.6%	+18.7%	+22.8%
Apr 6	Evercore ISI	Maintains	Outperform → Outperform	—	$50.21	$50.21	+0.0%	+1.9%	-0.2%	+1.9%	-2.7%	-4.6%
Mar 30	Guggenheim	Maintains	Buy → Buy	—	$44.53	$45.33	+1.8%	-2.9%	+6.7%	+11.3%	+12.8%	+14.9%
Feb 3	Barclays	Maintains	Overweight → Overweight	—	$46.81	$46.62	-0.4%	-1.0%	+2.8%	+0.6%	+5.2%	+1.4%
Feb 3	Evercore ISI	Maintains	Outperform → Outperform	—	$46.81	$46.62	-0.4%	-1.0%	+2.8%	+0.6%	+5.2%	+1.4%
Jan 26	Guggenheim	Maintains	Buy → Buy	—	$42.94	$42.68	-0.6%	-1.1%	-0.8%	-2.2%	-3.2%	-4.4%
Jan 8	TD Cowen	Maintains	Buy → Buy	—	$36.55	$36.19	-1.0%	-5.0%	-3.4%	+4.1%	+10.0%	+9.5%
Dec 15	Barclays	Maintains	Overweight → Overweight	—	$30.93	$31.78	+2.7%	+0.5%	+0.6%	+3.9%	+3.2%	+5.1%
Nov 17	Barclays	Maintains	Overweight → Overweight	—	$26.87	$26.74	-0.5%	-1.5%	-3.2%	-5.3%	-3.0%	+6.3%
Oct 7	Evercore ISI	Maintains	Outperform → Outperform	—	$31.85	$32.14	+0.9%	-2.3%	+3.0%	+0.1%	-2.1%	-5.4%
Oct 2	Barclays	Maintains	Overweight → Overweight	—	$29.26	$29.44	+0.6%	+4.9%	+6.2%	+8.9%	+6.4%	+12.1%
May 6	Goldman Sachs	Maintains	Buy → Buy	—	$35.93	$35.31	-1.7%	-8.9%	-8.8%	-9.2%	-14.2%	-8.3%
May 6	Baird	Maintains	Outperform → Outperform	—	$35.93	$35.31	-1.7%	-8.9%	-8.8%	-9.2%	-14.2%	-8.3%
May 6	Guggenheim	Maintains	Buy → Buy	—	$35.93	$35.31	-1.7%	-8.9%	-8.8%	-9.2%	-14.2%	-8.3%
May 6	JP Morgan	Maintains	Underweight → Underweight	—	$35.93	$35.31	-1.7%	-8.9%	-8.8%	-9.2%	-14.2%	-8.3%
Apr 10	Barclays	Maintains	Overweight → Overweight	—	$40.27	$37.84	-6.0%	-9.0%	-3.5%	-1.1%	-1.9%	-4.5%
Feb 4	Baird	Maintains	Outperform → Outperform	—	$52.75	$53.39	+1.2%	-1.4%	+1.7%	+1.8%	-0.9%	-7.8%
Feb 4	JP Morgan	Maintains	Underweight → Underweight	—	$52.75	$53.39	+1.2%	-1.4%	+1.7%	+1.8%	-0.9%	-7.8%
Feb 4	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$52.75	$53.39	+1.2%	-1.4%	+1.7%	+1.8%	-0.9%	-7.8%
Nov 26	TD Cowen	Maintains	Buy → Buy	—	$46.40	$46.58	+0.4%	-0.1%	+4.1%	+6.0%	+8.4%	+9.1%
Nov 19	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$41.43	$41.72	+0.7%	-0.3%	-0.8%	+0.6%	+1.9%	+12.0%
Nov 19	Barclays	Maintains	Overweight → Overweight	—	$41.43	$41.72	+0.7%	-0.3%	-0.8%	+0.6%	+1.9%	+12.0%
Nov 19	Baird	Maintains	Outperform → Outperform	—	$41.43	$41.72	+0.7%	-0.3%	-0.8%	+0.6%	+1.9%	+12.0%
Oct 17	Leerink Partners	Maintains	Market Perform → Market Perform	—	$45.07	$45.24	+0.4%	+1.0%	+4.1%	+0.6%	-2.8%	-8.8%
Oct 1	Evercore ISI	Maintains	Outperform → Outperform	—	$45.18	$44.63	-1.2%	-3.9%	-4.2%	-5.3%	-4.1%	-6.7%
Aug 5	Barclays	Maintains	Overweight → Overweight	—	$42.97	$38.99	-9.3%	+5.5%	+7.6%	+3.7%	+5.7%	+2.3%
Aug 5	JP Morgan	Maintains	Underweight → Underweight	—	$42.97	$38.99	-9.3%	+5.5%	+7.6%	+3.7%	+5.7%	+2.3%
Aug 5	Baird	Maintains	Outperform → Outperform	—	$42.97	$38.99	-9.3%	+5.5%	+7.6%	+3.7%	+5.7%	+2.3%
Jul 9	Goldman Sachs	Maintains	Buy → Buy	—	$48.95	$49.13	+0.4%	+3.2%	+4.2%	+7.2%	+9.2%	+14.7%
Jun 28	Barclays	Maintains	Overweight → Overweight	—	$47.48	$48.29	+1.7%	+3.8%	+3.1%	-0.3%	+1.1%	+2.1%
Jun 13	TD Cowen	Maintains	Buy → Buy	—	$52.44	$52.98	+1.0%	-0.8%	-5.0%	-6.6%	-3.6%	-7.1%
May 6	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$41.21	$41.48	+0.7%	+8.4%	+4.7%	+0.5%	+4.8%	+2.8%
May 3	Barclays	Maintains	Overweight → Overweight	—	$32.01	$38.28	+19.6%	+28.7%	+39.6%	+34.7%	+29.3%	+35.0%
May 3	Baird	Maintains	Outperform → Outperform	—	$32.01	$38.28	+19.6%	+28.7%	+39.6%	+34.7%	+29.3%	+35.0%
May 3	Evercore ISI	Maintains	Outperform → Outperform	—	$32.01	$38.28	+19.6%	+28.7%	+39.6%	+34.7%	+29.3%	+35.0%
Apr 10	Barclays	Maintains	Overweight → Overweight	—	$33.73	$31.32	-7.1%	-5.5%	-3.1%	-9.0%	-13.3%	-15.2%
Feb 5	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$36.59	$35.50	-3.0%	-0.5%	+1.0%	-4.4%	-0.2%	+4.4%
Jan 25	Barclays	Maintains	Overweight → Overweight	—	$32.67	$33.57	+2.8%	-0.8%	-1.2%	+6.4%	+1.6%	-0.8%
Jan 18	Goldman Sachs	Maintains	Buy → Buy	—	$34.84	$35.35	+1.5%	-2.8%	-3.6%	-0.2%	-1.3%	-6.2%
Jan 17	Goldman Sachs	Upgrade	Neutral → Buy	—	$35.27	$37.68	+6.8%	-1.2%	-4.0%	-4.7%	-1.4%	-2.5%
Aug 7	Barclays	Maintains	Overweight → Overweight	—	$22.98	$22.89	-0.4%	+3.4%	+1.5%	-1.7%	-0.8%	-2.9%
Jul 13	Goldman Sachs	Maintains	Neutral → Neutral	—	$23.21	$23.60	+1.7%	+0.7%	+0.4%	+4.1%	+8.1%	+12.1%
May 8	Baird	Maintains	Outperform → Outperform	—	$12.89	$12.91	+0.2%	+4.0%	+4.9%	+2.5%	-1.5%	-7.3%
May 8	Barclays	Maintains	Overweight → Overweight	—	$12.89	$12.91	+0.2%	+4.0%	+4.9%	+2.5%	-1.5%	-7.3%
Apr 19	Goldman Sachs	Maintains	Neutral → Neutral	—	$14.37	$13.95	-2.9%	+0.2%	-5.9%	-4.3%	-5.1%	-11.1%
Apr 18	Goldman Sachs	Maintains	Neutral → Neutral	—	$14.70	$14.80	+0.7%	-2.2%	-2.0%	-8.0%	-6.5%	-7.3%
Feb 6	Barclays	Maintains	Overweight → Overweight	—	$25.31	$25.93	+2.4%	-6.2%	+3.4%	+3.5%	-2.5%	-6.4%
Feb 6	Baird	Maintains	Outperform → Outperform	—	$25.31	$25.93	+2.4%	-6.2%	+3.4%	+3.5%	-2.5%	-6.4%
Feb 6	Goldman Sachs	Maintains	Neutral → Neutral	—	$25.31	$25.93	+2.4%	-6.2%	+3.4%	+3.5%	-2.5%	-6.4%
Jan 30	Barclays	Maintains	Overweight → Overweight	—	$29.15	$28.50	-2.2%	-3.1%	-1.6%	-0.2%	+6.0%	-13.2%

Recent Filings

8-K · 2.02 !! High

Twist Bioscience Corporation -- 8-K 2.02: Earnings Results

Twist Bioscience released Q1 2026 earnings results, providing investors with updated financial performance and operational metrics for the quarter ended March 31, 2026.

May 4

8-K · 8.01 !! High

Twist Bioscience Corporation -- 8-K 8.01: Material Event / Announcement

Twist Bioscience secured investor commitments with registration rights agreements, enabling shareholders to liquidate holdings through registered public offerings, reducing lock-up restrictions.

Feb 17

8-K

Twist Bioscience Corporation -- 8-K Filing

I cannot provide a meaningful analysis from this filing summary, as it contains only technical metadata and schema references without substantive business information.

Feb 6

8-K

Twist Bioscience Corporation -- 8-K Filing

Twist Bioscience exceeded expectations with record $103.7M quarterly revenue, 17% year-over-year growth, and raised full-year guidance to $435-440M, signaling strong momentum in synthetic biology markets.

Feb 2

Data updated apr 27, 2026 6:13am · Source: massive.com